INTRODUCTION
Hantavirus cardiopulmonary syndrome (HCPS) is a severe and often fatal infection of the lung and other tissues, caused by 1 of at least 16 hantaviruses (family Bunyaviridae, genus Hantavirus) distributed throughout most of the Americas [Schmaljohn and Hjelle, 1997; Koster and Hjelle, 2004] . Hantaviruses are negativestrand RNA viruses containing three segments, a small (S), medium (M), and large (L) segments encoding nucleocapsid (N), glycoproteins GPC, and RNA-dependent RNA polymerase, respectively. Most hantaviruses in the Americas, including the Sin Nombre virus (SNV) in North America and the Andes virus (ANDV) in South America, are associated with mortality rates of 20-35% and are contrasted with low levels of seroprevalence in endemic regions, usually below 2%. One exception is the Laguna Negra virus (LNV) in the Gran Chaco of western Paraguay, where indigenous peoples uncommonly experience symptomatic infection and mortality yet seroprevalence to hantavirus infection exceeds 20% in many communities [Ferrer et al., 1998; Williams et al., 1997] .
The other exception is Choclo virus (CHOV), the only virus ascribed to human disease in Panama [Vincent et al., 2000; Bayard et al., 2004] . CHOV was identified by RT-PCR from samples taken from the host Oligoryzomys fulvescens, a common peridomestic sigmodontine rodent in Panama. More than 140 cases of HCPS, including 28 fatalities, have been recorded in Panama since 2000. All hospitalized patients tested by RT-PCR and amplimer sequencing were shown to have CHOV infections (Pascale et al., unpublished work) . High serum antibody prevalence may be due to infection exclusively with CHOV or may be due in part to infections with other hantaviruses. Hantaviruses in Panama not associated with human disease include Rio Segundo virus [Hjelle et al., 1995] , Calabazo virus (CALV) [Vincent et al., 2000; Salazar-Bravo et al., 2004] and an unnamed hantavirus in Sigmodon hirsutus [Armien et al., 2009] . Extensive cross-reactivity to nucleoproteins of the American hantaviruses prevents the use of EIA or Western blot technologies when assigning an infecting strain . Studies utilizing neutralizing antibody specificities, on the other hand, may permit tentative assignment [Chu et al., 1994] .
This study was undertaken to culture CHOV, obtain a complete sequence of the viral S and M segments, identify phylogenetic relationships, and develop a focus neutralization assay in order to implicate CHOV in the high antibody prevalence among Panamanians.
METHODS

Viral Isolation
Virus was obtained from the spleen of a rodent, O. fulvescens (specimen voucher no. NK101588, UNM MSB 96073), captured on March 6, 2000 in Las Tablas, Los Santos Province, Panama. The virus is named for a cantina ''El Choclo'' of interesting reputation in the neighborhood Barriada 8 Noviembre near Las Tablas. One hundred milligram of tissue was homogenized by a bead beater using 2.5-mm zirconium/silica beads in phosphate-buffered saline (PBS) and diluted 1:50, 1:200, and 1:1,000 in 1.0 ml complete Vero media (Eagle's minimal essential medium [EMEM] containing 10% fetal bovine serum [FBS] , gentamicin [50 mg/ml], and 20 mM glutamine). Vero E6 cells (Vero C1008, ATCC CRL 1586, passage 8) were grown to confluency in 25-cm 2 flasks in Vero complete media. Media were removed from the monolayer and the diluted homogenates were added, incubated on a slow plate rocker at room temperature for 2 hr, then the tissue homogenate was removed. Fresh media with 2.5% FBS were added and the monolayers were incubated at 368C in a 5% CO 2 atmosphere, with media changed twice weekly. Passage of the monolayer to fresh flasks after trypsinization (0.5% trypsin/5 mM EDTA) was accomplished after 4 weeks (first passage) and thereafter every 2-2.5 weeks. All experiments involving infectious viruses were performed in a biosafety level 3 laboratory.
RT-PCR
A nested reverse transcriptase-polymerase chain reaction (RT-PCR) was used to detect viral RNA in culture supernatants from each passage. Typically, 170-ml aliquots (approximately 2 mg total RNA) of supernatant media was extracted using the QIAampViral RNA kit (Qiagen, Inc., Valencia, CA) according to the manufacturer's directions. RT-PCR was initiated using AMVrt and Amplitaq LD with the outer antisense primer for 1 hr at 428C. Subsequent reaction conditions were 948C for 5 min, followed by 8 cycles consisting of 10 sec at 948C, 20 sec at 508C, and 60 sec at 728C, and finally by 28 cycles with the annealing temperature of 558C. The outer primers at the 5 0 end of the segment were 5 0 -ACTGCACGGCAAAAGCTTAAA-3 0 (58F) and 5 0 -GGATATAAGCACCAATTGACCT-3 0 (379R) producing a 320-bp amplimer. The inner pair was 5 0 -GGA-CCCGGATGAAGTTAACAA-3 0 (102F) and 5 0 -AATTT-TTGAGCTGCCACCAA-3 0 (222R) producing a 120 bp amplimer. The products were visualized on agarose gel, purified and sequenced to confirm specificity to CHOV.
Focus and Neutralization Assays
Replicating virus was titered using a focus assay as published [Bharadwaj et al., 2000] . Vero E6 cells were seeded onto 48-well plates and incubated until confluent. Tenfold dilutions (1:10-1:10 7 ) of virus-containing culture supernatant were added to the monolayers in a 200-ml volume of viral culture medium (EMEM, HEPES buffer, 2.5% FBS, and 50 mg/ml gentamicin) and incubated for 2 hr at 378C. After adsorption, the supernatant was aspirated and 1 ml/well of viral overlay media (VCM and 1.2% methylcellulose) was added and incubated for 7 days. After 7 days the overlay media were removed; the monolayer was washed once with PBS. Ice-cold methanol containing 0.5% H 2 O 2 was added and incubated at room temperature for 30 min; fixative then was aspirated and PBS added for storage until immunoperoxidase assay.
For the immunoperoxidase assay, fixed cell monolayers were washed twice with PBS, and 200 ml/well of 1:1,000-diluted rabbit anti-SN virus serum was incubated for 1 hr at 378C. After aspiration and washing twice with PBS, 200 ml of peroxidase-conjugated AffinPure Goat anti-rabbit IgG (H þ L) (Pierce Immunochemicals, Rockford, IL) diluted 1:1,000 in PBS was added and incubated for 1 hr at 378C. Following aspiration and washing, 200 ml of DAB/metal concentrate diluted with 1Â peroxidase substrate buffer was added to the monolayers and incubated until brown foci appeared, usually 15-30 min. Foci/well were enumerated with a 20Â inverted scope ocular.
Neutralizing antibody was measured in human serum using diluted test sera in the focus titration assay. Serum samples containing anti-hantavirus antibody were collected from family members and neighbors of HCPS patients in the community of San Jose, Los Santos Province from 2001 to 2003. Serum diluted (1:20, 1:100, 1:200, 1:400, 1:800, 1:1,600, 1:3,200, 1:6,400, and 1:12,800 dilutions) was incubated for 2 hr at 378C with stock virus diluted to a concentration of 35-50 focusforming units (FFU)/well prior to incubation on Vero cell monolayers. Neutralizing antibody titers were expressed as the reciprocal of the highest serum dilution that results in an 80% reduction in the number of foci compared to virus controls. Discrepant results were resolved by two additional focus neutralization assays. Stock CHOV used was E6 passage 3, with a titer of 4.3 log 10 FFU/ml. Stock SNV and ANDV demonstrated approximately the same titer in the focus assay titration as was documented by the originating laboratory.
Viral Sequencing
To sequence complete S and M segments, nested primers were designed from consensus sequences of ANDV and LNV viruses in GenBank. To sequence the 5 0 and 3 0 termini of each segment, dephosphorylated terminal nucleotides were ligated with T4 ligase and appropriately sized amplimers were cloned into pCRII vector (Invitrogen, Carlsbad, CA). The resulting clones were sequenced by the dideoxy method. Sequences were acceptable only if forward and reverse sequencing results agreed. Multiple overlapping amplimers were sequenced to achieve an 80% duplication of the entire genome.
Phylogenetic Analysis
Sequences of the N protein gene of four strains of ANDV and one strain each of 20 other hantaviruses were compared to the sequence of the CHOV. The sequence of the GPC gene of the CHOV was compared to sequences of 4 strains of ANDV and 20 other hantaviruses (Table I ). The accession numbers of closely related viruses were Maporal virus (MAPV) (N, AY267347; GPC, AY363170) and LNV (N, AF005727; GPC, AF005728). Sequences were aligned using ClustalX [Thompson et al., 1994] followed by visual inspection using MacClade 4 [Maddison and Maddison, 2003] . The N protein and GPC gene sequences were 1,302 (with stop codon) and 3,465 characters in length, respectively.
Phylogenetic analyses of DNA sequences were conducted using maximum parsimony (MP) and maximum likelihood (ML) in the software package PAUP* 4.0b10 [Swofford, 2002] . Fulhorst et al. [2004] excluded third base positions from their MP and ML analyses. Third base positions were included but only for transversion changes. Transversion changes continued to increase as genetic distance increased, suggesting that a phylogenetic signal may still be present for these changes at the third position, yet transition changes plateau, suggesting saturation of substitutions has occurred for transitions at the third base position. In the MP analysis all characters were weighted based on their rescaled consistency index (RCI). A heuristic search option with 100 replications of random addition of taxa and TBR branch swapping was used to generate parsimony trees. Bootstrap support [Felsenstein, 1985] for results of MP analyses were based on 1,000 repetitions of resampling data using the heuristic search option, with 10 replications of random addition of taxa. Modeltest (v 3.06) [Posada and Crandall, 1998 ] was used to calculate the appropriate model for ML analyses. The GTR þ G þ I (0.6787 and 0.3440 for G and I, respectively) was used to construct phylogenies for the S segment and the GTR þ G (0.3439) model was used to construct the M segment phylogeny based on the results of the Modeltest analysis.
RESULTS
Isolation of the Virus
RT-PCR of serial supernatants from blind passages identified the appearance of detectable viral RNA from animal #588 by the fourth blind passage in both tissue inocula diluted 1:50 and 1:1,000. Virus was first detected by focus titration assay from the third passage at <100 FFU/ml, and the highest level of virus was found in the sixth passage with a titer of 5 Â 10 4 FFU/ml. Viral RNA was extracted from sixth passage supernatants, or third passage of virus-positive supernatants, for subsequent genomic sequencing.
Nucleotide Sequence Analysis
The S segment of CHOV isolate 588 (accession no. DQ285046) was 1,516 nt in length, of which 1,302 bases encode a predicted nucleocapsid protein 434 amino acids in length, beginning at nt 43. The S segment also contains a potential second open-reading frame (ORF) beginning at nt 122, with a predicted protein of 63 amino acids in length. Terminal nucleotides were conserved as seen in other hantaviruses [Chizhikov et al., 1995] with the 32-and 28-nt equivalent to the 5 0 and 3 0 ends, respectively, being identical to those of ANDV and LNV. The 20-nt differences between the CHOV and SNV in the S segment coding region included 16 nonsynonymous changes.
Comparison of the CHOV S segment sequences with those of other hantaviruses indicates the highest degree of identity with South American viruses (78.3-79.8% nt; 89.4-91.2% aa; Table II ). Nucleotide similarity between CHOV and the North American viruses was close to that of the South American viruses and ranged from 75.9% to 79.3% (83.2-89.2% aa). Comparison of deduced N protein amino acid sequences shows an 89.9% identity to MAPV, an 88.5% identity to SNV, and a 90% identity to ANDV.
Sequence Analysis of the M Segment
The complete M segment (accession no. DQ285047) is 3,465 nt in length, encoding a glycoprotein precursor of 1,155 amino acids. Again, CHOV is more similar to the South American viruses (73.4-74.9% and 82.6-83.8% nt and aa, respectively; Table III American viruses had nucleotide similarity ranging from 70.8% to 72.3% and amino acid similarity from 76.1% to 79.6%. Comparison of amino acid sequences shows that CHOV has an 83.6% identity to MAPV, a 79.6% identity to SNV, and a 83.7% identity to ANDV.
The tree topologies for the MP and ML analyses were similar. CHOV was basal to the South American viruses in the ML analyses for the S segment, whereas it formed a polytomy with MAPV and the remaining South American viruses in the MP analyses (Fig. 1A,B) . The relationship of CHOV to the South American viruses also was found in both the ML and MP analyses using the M segment (Fig. 1C,D) . However, the bootstrap support for this relationship was stronger than in the analysis of the S segment. The differences in tree topologies between this study and that of Fulhorst et al. [2004] can be explained by low bootstrap support of two nodes (compare Fig. 1 to their Fig. 1 [p. 141] ). Because bootstrap support is low in analyses from both studies, it is difficult to reject either hypothesis. In both studies the North American viruses are paraphyletic with respect to the South American viruses.
Neutralization of Choclo Virus by Human Sera
The presence of neutralizing antibody was detected by the focus reduction assay in sera from all six individuals with RT-PCR-confirmed CHOV infection and typical HCPS. Three adults with 3-5 days of symptomatic acute disease and who required intubation had lower serum titers (1:200-1:1,600) than the three individuals with milder disease who did not require intubation and who were tested 30-60 days after hospitalization (Table IV) . Among 10 individuals with IgG antibody, as detected by EIA and strip immunoblot, and who denied previous hospitalization for respiratory infection, 9 had significant neutralizing antibody to CHOV, with titers ranging from 1:100 to 1:6,400. One individual in this group did not have a detectable CHOV-neutralizing antibody, as determined in four independent assays. Seronegative controls from Panama did not have neutralizing antibody to CHOV, and no subject from Panama had neutralizing antibody to either SNV or ANDV. Two patients with mild HCPS in New Mexico had neutralizing antibody to SNV isolate 777 but not to CHOV. The hantaviruses identified by RT-PCR in Z. brevicauda (CALV) and in S. hirsutus (unnamed virus) could not be grown in Vero cell culture despite multiple blind passages in two different laboratories, and therefore neutralizing antibody to these viruses is not reported.
DISCUSSION
The first goal of the study was to culture the virus and facilitate accurate identification of phylogenetic relationships. The complete genomic sequence of the S and M segments permitted the conclusion that CHOV is distinct from all other hantaviruses, according to established criteria [Elliott et al., 2000] . Even though CHOV and MAPV share the same host O. fulvescens, these two strains are approximately 10% distinct at the This distinction is likely due to independent evolution permitted by the extensive ecologic and physical separation between western Panama and western Venezuela. Rodents in the sigmodontine genus Oligoryzomys are natural hosts for at least six hantaviruses [Bharadwaj et al., 1997; Powers et al., 1999; Bohlman et al., 2002; Gonzalez Della Valle et al., 2002; Meissner et al., 2002; Medina et al., [Bohlman et al., 2002; Medina et al., 2009] , suggesting recent divergence. The greater diversity of CHOV from other oryzomine hantaviruses suggests its more remote divergence from the common ancestor.
The second goal of the study was to use the specificity of the neutralization assay to indicate whether the high serum antibody prevalence was due to previous CHOV infection. The focus neutralization assay of sera from CHOV-positive PCR-confirmed HCPS patients demonstrated the presence of neutralizing antibody titers of levels similar to other published reports [Bharadwaj et al., 2000] . As expected, there was no cross-neutralization between CHOV, ANDV, and SNV, but crossneutralization studies with more closely related viruses, including CALV [Vincent et al., 2000] and MAPV, a hantavirus isolated from O. fulvescens in Venezuela [Milazzo et al., 2002; Fulhorst et al., 2004] , is needed for definitive specificity.
In five communities in the Azuero peninsula investigators found antibody prevalence ranging from 3% to 45% . Antibody was detected in samples from children as young as 4 years of age and increases steadily to highest prevalence in the 40-to 50-year-old cohort, suggesting that steady exposure and infection occurs throughout life in rural areas. From these cohort data, it is estimated that among the 250,000 people of the Azuero peninsula there may be more than 10,000 individuals with serum anti-hantavirus antibody. Questionnaires indicated that none of the 275 antibody-positive individuals tested had given a history compatible with an HCPS-like illness, although histories of febrile respiratory illnesses not requiring hospitalization were common ]. An ongoing clinical trial in four clinics during 2 years of observation has identified 110 individuals with fever and antihantavirus antibody detected by IgM-ELISA. CHOV RNA was detected in acute blood samples by RT-PCR, yet no progression to symptomatic pulmonary disease was found (B. Armien, unpublished work).
If the majority of antibody positive individuals were infected with CHOV, as suggested by neutralization assays, and if the reported 140 cases of HCPS is a good estimation of total cases, the ratio of mild or asymptomatic CHOV infection to HCPS may be as high as 50:1 in Panama. LNV may also be associated with a high ratio of mild-to-severe infection, although strain-specific neutralization titers have not been published [Chu et al., 2006] . In regions where multiple hantaviruses co-circulate in rodent populations, such as Panama, Paraguay [Chu et al., 2006] , and Brazil [Figueiredo et al., 2009; Raboni et al., 2009] , neutralization assay studies can identify the dominant hantaviruses that infect humans. Since each rodent host has habitat preferences [Chu et al., 2003; Armien et al., 2009] , the identification of hantavirus species causing human disease can have useful public health implications.
